Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fleischmann

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Acta Haematologica|January 1, 1970
Aneuploidy in paroxysmal nocturnal haemoglobinuriaT Fleischmann, F Bodor
Krankenpflege Journal|January 1, 1994
[Alternative skin protection]T Fleischmann, I Schneider
Orvosi Hetilap|February 9, 1975
[Marker chromosome in myeloproliferative syndrome]T Fleischmann, F Krizsa
Acta Haematologica|January 1, 1975
Marker chromosome in myeloproliferative syndromeT Fleischmann, F Krizsa
Orvosi Hetilap|December 8, 1974
[A simple method for the relief study of human chromosomes]T Fleischmann, F Joó
The American Journal of Emergency Medicine|January 1, 1990
Efficiency and cost-effectiveness of advanced EMS in West GermanyG Riediger, T Fleischmann-Sperber
Orvosi Hetilap|May 10, 1981
[Cytogenetic studies of malignant follicular centrocyte related lymphomas]T Fleischmann, I Kaszás, M Bak
Oncology|January 1, 1991
Treatment of resistant Hodgkin's disease with CCNU, etoposide and prednimustine (CEP)I Szántó, T Fleischmann, S Eckhardt
Oncology|January 1, 1989
Prednimustine treatment in malignant lymphomasI Szántó, T Fleischmann, S Eckhardt
Pathologica|January 1, 1981
Characteristics of human lymphoblastoid cell lines established in cultureI Pályi, J Sugár, T Fleischmann
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Acta Haematologica|January 1, 1970
Aneuploidy in paroxysmal nocturnal haemoglobinuriaT Fleischmann, F Bodor
Krankenpflege Journal|January 1, 1994
[Alternative skin protection]T Fleischmann, I Schneider
Orvosi Hetilap|February 9, 1975
[Marker chromosome in myeloproliferative syndrome]T Fleischmann, F Krizsa
Acta Haematologica|January 1, 1975
Marker chromosome in myeloproliferative syndromeT Fleischmann, F Krizsa
Orvosi Hetilap|December 8, 1974
[A simple method for the relief study of human chromosomes]T Fleischmann, F Joó
The American Journal of Emergency Medicine|January 1, 1990
Efficiency and cost-effectiveness of advanced EMS in West GermanyG Riediger, T Fleischmann-Sperber
Orvosi Hetilap|May 10, 1981
[Cytogenetic studies of malignant follicular centrocyte related lymphomas]T Fleischmann, I Kaszás, M Bak
Oncology|January 1, 1991
Treatment of resistant Hodgkin's disease with CCNU, etoposide and prednimustine (CEP)I Szántó, T Fleischmann, S Eckhardt
Oncology|January 1, 1989
Prednimustine treatment in malignant lymphomasI Szántó, T Fleischmann, S Eckhardt
Pathologica|January 1, 1981
Characteristics of human lymphoblastoid cell lines established in cultureI Pályi, J Sugár, T Fleischmann
Pageof 5